Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by an excessive expansion of a CAG trinucleotide repeat in the gene encoding the protein huntingtin, resulting in an elongated stretch of glutamines near the N-terminus of the protein. Here we report the derivation of a collection of 11 induced pluripotent stem (iPS) cell lines generated through somatic reprogramming of fibroblasts obtained from the R6/2 transgenic HD mouse line. We show that CAG expansion has no effect on reprogramming efficiency, cell proliferation rate, brain-derived neurotrophic factor level, or neurogenic potential. However, genes involved in the cholesterol biosynthesis pathway, which is altered in HD, are also affected in HD-iPS cell lines. Furthermore, we found a lysosomal gene upregulation and an increase in lysosome number in HD-iPS cell lines. These observations suggest that iPS cells from HD mice replicate some but not all of the molecular phenotypes typically observed in the disease; additionally, they do not manifest increased cell death propensity either under self-renewal or differentiated conditions. More studies will be necessary to transform a revolutionary technology into a powerful platform for drug screening approaches.
Introduction
Huntington's disease (HD) is an untreatable, progressive genetic neurodegenerative disorder caused by an unstable expansion of the CAG repeat within the coding region of the IT-15 gene. This gene encodes for the huntingtin (HTT) protein and the mutation results in an elongated stretch of glutamines in the N-terminus of the protein (HD Collaborative Research Group, 1993) . This HTT mutation is responsible for massive brain neurodegeneration characterized by the prevalent loss of efferent medium spiny neurons in the striatum, the main input station of the basal ganglia circuit, but progressively involves cortical neuronal structures as well (Reiner et al., 1988; Rosas et al., 2003 Rosas et al., , 2005 Rosas et al., , 2008 .
HD is characterized by chorea, cognitive abnormalities, and psychiatric disturbances that manifest in mid-adulthood and progress inexorably toward death. The CAG expansion in HTT is the triggering event that endows the protein with new toxic functions that are deleterious to striatal and cortical neurons. At the same time, the specificity of the neuronal loss may be due to the protein context in which the CAG is expanded (Cattaneo, 2001) ; the mutation also affects the ability of normal HTT to exert beneficial activities for the neurons that degenerate in HD (Zuccato et al., 2010) .
While our understanding of HD pathophysiology is advancing rapidly, our knowledge is still incomplete. Since HD is caused by a single mutation, introduction of the mutant gene into non-human primates, mice, flies, fishes, and worms has generated disease models that have been extremely valuable in the identification of pathways affected by the mutation and as validation tools for ex vivo-identified targets (Zuccato et al., 2010) . In parallel, since the year 2000 we and others have reported the generation of a large collection of brain-derived cell lines from rodents, including the first clones of immortalized ST14A cells carrying the full length or truncated normal or mutant HTT gene (Rigamonti et al., 2000) , their inducible variants (Sipione et al., 2002) , knock-in cell lines (Trettel et al., 2000) , and, more recently, rodent-and human-derived neural stem cell lines carrying the mutant HTT gene (unpublished results).
Collectively, these and other cell lines have been instrumental in providing the first indications of a loss-of-HTT-function mechanism operating in HD, and were used to deliver the first evidence of losses in BDNF mRNA and protein levels and reduced transcription of other NRSE-RE1-controlled neuronal genes (Rigamonti et al., 2007; Zuccato et al., 2003 Zuccato et al., , 2007 . In addition, gene expression profiling of ST14A cell line stably expressing an inducible mutant HTT construct revealed a defect in the cholesterol biosynthesis pathway that was confirmed Abbreviations: iPS, induced pluripotent stem cells; HD, Huntington's disease; wt, wild type; HTT, huntingtin; BDNF, brain-derived neurotrophic factor; PH3, phosphohistone H3; PI, propidium iodide; GFAP, glial fibrillary acid protein; MAP2ab, microtubule-associated protein 2 ab; GAP-43, growth associated protein 43; Hmgcr, 3-hydroxy-3-methylglutaryl-Coenzyme A reductase; 7dhcr, 7-dehydrocholesterol reductase; Cyp51, cytochrome P450 Lanosterol 14 alpha-demethylase; TFEB, Transcription Factor EB; Ctsf, cathepsin F; Tpp1, tripeptidyl peptidase; Lamp1, lysosomal-associated membrane protein; TTF, tail-tip fibroblasts; MEF, mouse embryonic fibroblasts; ES, embryonic stem.
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